Portal de Periódicos da CAPES

POT1 loss-of-function variants predispose to familial melanoma

2014; Nature Portfolio; Volume: 46; Issue: 5 Linguagem: Inglês

10.1038/ng.2947

1546-1718

Carla Daniela Robles‐Espinoza, Mark Harland, Andrew Ramsay, Lauren G. Aoude, Vı́ctor Quesada, Zhihao Ding, Karen A. Pooley, Antonia L. Pritchard, Jessamy Tiffen, Mia Petljak, Jane M. Palmer, Judith Symmons, Peter A. Johansson, Mitchell Stark, Michael G. Gartside, Helen Snowden, Grant W. Montgomery, Nicholas G. Martin, Jimmy Z. Liu, Jiyeon Choi, Matthew Makowski, Kevin M. Brown, Alison M. Dunning, Thomas Keane, Carlos López‐Otín, Nelleke A. Gruis, Nicholas K. Hayward, D. Timothy Bishop, Julia Newton‐Bishop, David J. Adams,

CRISPR and Genetic Engineering

David Adams, Julia Newton-Bishop, Timothy Bishop, Nicholas Hayward and colleagues identify loss-of-function variants in POT1 in several families with early onset multiple primary melanoma. They further show that these variants disrupt telomere binding by POT1 and are associated with increased telomere length. Deleterious germline variants in CDKN2A account for around 40% of familial melanoma cases1, and rare variants in CDK4, BRCA2, BAP1 and the promoter of TERT have also been linked to the disease2,3,4,5. Here we set out to identify new high-penetrance susceptibility genes by sequencing 184 melanoma cases from 105 pedigrees recruited in the UK, The Netherlands and Australia that were negative for variants in known predisposition genes. We identified families where melanoma cosegregates with loss-of-function variants in the protection of telomeres 1 gene (POT1), with a proportion of family members presenting with an early age of onset and multiple primary tumors. We show that these variants either affect POT1 mRNA splicing or alter key residues in the highly conserved oligonucleotide/oligosaccharide-binding (OB) domains of POT1, disrupting protein-telomere binding and leading to increased telomere length. These findings suggest that POT1 variants predispose to melanoma formation via a direct effect on telomeres.